GENETIC AND PHYSIOLOGICAL ASSOCIATION OF DIABETES SUSCEPTIBILITY WITH RAISED NA+/H+ EXCHANGE ACTIVITY

被引:75
作者
MORAHAN, G [1 ]
MCCLIVE, P [1 ]
HUANG, DX [1 ]
LITTLE, P [1 ]
BAXTER, A [1 ]
机构
[1] BAKER MED RES INST,PRAHRAN,VIC 3181,AUSTRALIA
关键词
AUTOIMMUNITY; TYPE I DIABETES; NONOBESE DIABETIC MICE; ANTIPORTER; GENE MAPPING;
D O I
10.1073/pnas.91.13.5898
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Insulin-dependent diabetes mellitus is a multigenic autoimmune disease, for which one of the best animal models is the nonobese diabetic (NOD) mouse strain. In both humans and NOD mice, major histocompatibility complex genes are implicated as risk factors in the disease process. Other susceptibility genes are also involved, and a number have been mapped in the mouse to specific chromosomal locations. To identify further susceptibility genes, diabetic backcross mite, produced after crossing NOD/Lt to the nondiabetic strains SJL and C57BL/6 (B6), were examined for markers not previously associated with disease susceptibility. Linkage was found to loci on chromosomes 4 and 14. Of the candidate loci on chromosome 4, the gene encoding the Na+/H+ exchanger-1, Nhe-1, was the most likely, since the NOD allele was different from that of both nondiabetic strains. NOD lymphocytes were found to have a higher level of Na+/H+ exchange activity than lymphocytes from either B6 or SJL mice. Since the chromosome 4 susceptibility gene is recessive, the B6 allele should prevent diabetes. This prediction was tested in fourth-generation backcross mice, selected for retention of the B6 allele at Nhe-1. Mice homozygous for Nhe-1 developed diabetes after cyclophosphamide treatment, but heterozygotes were largely protected from disease. These results implicate the Na+/H+ exchanger (antiporter) in the development of type 1 diabetes and may provide a screening test for at-risk individuals as web as offering prospects for disease prevention.
引用
收藏
页码:5898 / 5902
页数:5
相关论文
共 32 条
  • [31] GENETIC-CONTROL OF AUTOIMMUNITY IN TYPE-1 DIABETES
    TODD, JA
    [J]. IMMUNOLOGY TODAY, 1990, 11 (04): : 122 - 129
  • [32] WAKABAYASHI S, 1992, REV PHYSIOL BIOCH P, V119, P157